196 related articles for article (PubMed ID: 33210244)
21. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
[TBL] [Abstract][Full Text] [Related]
22. DMCM: a potent convulsive benzodiazepine receptor ligand.
Petersen EN
Eur J Pharmacol; 1983 Oct; 94(1-2):117-24. PubMed ID: 6317396
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effectiveness and tolerability of perampanel and brivaracetam: a real-world, observational, retrospective study.
Liguori C; Manfredi N; Renna R; Izzi F; Pagliuca M; Pagliuca F; Mercuri NB; Fabio P
Epileptic Disord; 2020 Jun; 22(3):309-316. PubMed ID: 32540833
[TBL] [Abstract][Full Text] [Related]
24. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland.
Väätäinen S; Soini E; Peltola J; Charokopou M; Taiha M; Kälviäinen R
Adv Ther; 2020 Jan; 37(1):477-500. PubMed ID: 31808053
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic data on brivaracetam, lacosamide and perampanel during pregnancy and lactation.
Landmark CJ; Rektorli L; Burns ML; Revdal E; Johannessen SI; Brodtkorb E
Epileptic Disord; 2021 Apr; 23(2):426-431. PubMed ID: 33935028
[TBL] [Abstract][Full Text] [Related]
26. Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid.
Czuczwar SJ; Meldrum B
Eur J Pharmacol; 1982 Sep; 83(3-4):335-8. PubMed ID: 6293844
[TBL] [Abstract][Full Text] [Related]
27. Anticonvulsant effects of methyl ethyl ketone and diethyl ketone in several types of mouse seizure models.
Hasebe N; Abe K; Sugiyama E; Hosoi R; Inoue O
Eur J Pharmacol; 2010 Sep; 642(1-3):66-71. PubMed ID: 20553923
[TBL] [Abstract][Full Text] [Related]
28. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
Yang XM; Luo ZP; Zhou JH
J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863
[TBL] [Abstract][Full Text] [Related]
29. Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle protein.
Okada M; Fukuyama K; Shiroyama T; Ueda Y
Biomed Pharmacother; 2021 Jun; 138():111462. PubMed ID: 33706129
[TBL] [Abstract][Full Text] [Related]
30. Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
Turski L; Stephens DN; Jensen LH; Petersen EN; Meldrum BS; Patel S; Hansen JB; Löscher W; Schneider HH; Schmiechen R
J Pharmacol Exp Ther; 1990 Apr; 253(1):344-52. PubMed ID: 1970362
[TBL] [Abstract][Full Text] [Related]
31. Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors.
Im HK; Im WB; Carter DB; McKinley DD
Br J Pharmacol; 1995 Mar; 114(5):1040-4. PubMed ID: 7780638
[TBL] [Abstract][Full Text] [Related]
32. Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors.
Nielsen EB; Jepsen SA; Nielsen M; Braestrup C
Life Sci; 1985 Jan; 36(1):15-23. PubMed ID: 2981379
[TBL] [Abstract][Full Text] [Related]
33. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of antiepileptic drugs and beta-carbolines on seizures induced by excitatory amino acids.
Turski L; Niemann W; Stephens DN
Neuroscience; 1990; 39(3):799-807. PubMed ID: 2097526
[TBL] [Abstract][Full Text] [Related]
35. Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model.
Wu T; Ido K; Ohgoh M; Hanada T
Epilepsy Res; 2019 Aug; 154():42-49. PubMed ID: 31035244
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat.
Eastman CL; Fender JS; Klein P; D'Ambrosio R
J Pharmacol Exp Ther; 2021 Dec; 379(3):310-323. PubMed ID: 34593559
[TBL] [Abstract][Full Text] [Related]
37. Neural Networks in Generalized Epilepsy and Novel Antiepileptic Drugs.
Werner FM; Coveñas R
Curr Pharm Des; 2019; 25(4):396-400. PubMed ID: 30892153
[TBL] [Abstract][Full Text] [Related]
38. Role of the NMDA receptor complex in DMCM-induced seizure in mice.
Tsuda M; Suzuki T; Misawa M
Neuroreport; 1997 Feb; 8(3):603-6. PubMed ID: 9106731
[TBL] [Abstract][Full Text] [Related]
39. Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM).
Kirby LG; Rowan GA; Smith RL; Lucki I
Psychopharmacology (Berl); 1994 Jan; 113(3-4):351-60. PubMed ID: 7862845
[TBL] [Abstract][Full Text] [Related]
40. Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.
Jackson HC; Hansen HC; Kristiansen M; Suzdak PD; Klitgaard H; Judge ME; Swedberg MD
Eur J Pharmacol; 1996 Jul; 308(1):21-30. PubMed ID: 8836628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
